The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
about
Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic EventsNatriuretic peptides as biomarkers in heart failureDepletion of proBNP1-108 in patients with heart failure prevents cross-reactivity with natriuretic peptidesSecretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure.An antibody reactive to the Gly63-Lys68 epitope of NT-proBNP exhibits O-glycosylation-independent binding.BNP molecular forms and processing by the cardiac serine protease corin.Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure.The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes.Corin in clinical laboratory diagnosticsAberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure.Reference materials and reference measurement procedures: an overview from a national metrology institute.Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes.Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.A review on B-type natriuretic peptide monitoring: assays and biosensorsAnalytical Issues with Natriuretic Peptides - has this been Overly Simplified?Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides.The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.Biochemistry of B-type natriuretic peptide--where are we now?Natriuretic peptides in the diagnosis and management of chronic heart failure.B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications.Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.Diverse molecular forms of plasma B-type natriuretic peptide in heart failure.MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides.Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.State of the art of immunoassay methods for B-type natriuretic peptides: An update.BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization.A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing.Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency.MiR30-GALNT1/2 Axis-Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts.A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric proteinPro-B-type natriuretic peptide is cleaved intracellularly: impact of distance between O-glycosylation and cleavage sites.NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity.Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population.How many human proteoforms are there?
P2860
Q26778333-C10F7D57-02CD-4D47-92F9-C4E482ED7E35Q27012872-85236570-78AB-43B5-9B4F-369F7CE32905Q28533555-1A5FF35C-37DE-4EDA-8ECD-00176B0C8024Q33994980-9B1BBD55-1663-44F1-9466-79892FC226EEQ34284107-B5BA6053-6935-4E0B-8914-E0BB92A85760Q34369603-6461B1B8-0152-4B9F-B47C-027F4F14BF03Q34568189-12E52842-31FA-45D7-8417-D821B7AE5137Q35131225-BDCF90FA-3C99-474F-A30C-D35053FE80D4Q35154172-3E52314A-5D30-4E95-A0D0-A318BA8DF92AQ35634038-8630A906-02A2-4960-9F88-95C0A9384A2DQ36046973-604699FF-A012-4695-B67E-7152E9ABCB1DQ36522969-A4A33452-0BFA-4032-A799-E0A91D1C869DQ36790719-23E7C5CE-9BC8-4E21-A4D2-A76CB738D149Q37076096-552772E5-42E6-4F2D-A86F-31674FA6CCC9Q37171880-EC6B60B5-A0D5-4F5F-AD9F-251FDC57B013Q37229313-5F550C4B-7E43-4D2B-AD74-0E759B636E37Q37251037-EA51C405-7645-476B-B5C7-F8B9F78B84BAQ37277937-36A68E07-87C1-42BD-8E41-281253C53F96Q37289418-B0728970-22A0-4B21-9BB1-547F93915FD3Q37447544-8639AF40-101E-458E-9CA5-4A12116C4D62Q37734430-E5DD3E43-0877-494C-8157-57714BD04451Q37835560-E781186A-D685-4BBC-9413-FA05318B83B8Q37845737-77E50C43-7445-44EA-81BB-2BC7BEEFD0DEQ38065253-FEAB5481-F055-4519-A517-C35661198CE7Q38261513-486A6442-B186-445E-B3AE-046C47FFBB69Q38303192-1E2CBF33-A459-4471-B112-BDF3451D5C48Q38324210-3A9C4B2A-141B-4A66-BA06-2669A20EAF1CQ38424871-38B52C84-91D9-418E-819B-B29871A5539AQ38509576-89C0545D-62CC-41DF-ACBE-D7153F0FF333Q38837698-B63C080C-CF70-4F8E-9612-719517C0DA43Q39102349-11B4E029-B77D-4FBA-80A0-8CADDC2CB64BQ39244694-123B5038-A524-43C5-8F74-AB0EE82B43DBQ39721683-1BE35743-83EB-41CB-B82E-6BE7B82CE359Q40954684-AB5B0780-2DB1-4D30-A121-F23E00239B91Q41102306-B4F8D0E3-FBFA-428F-96EA-E3AF03BB59D1Q41810604-F0C4AF88-3014-4B19-80A0-7392056369F1Q46706147-1E121B5F-35D6-446C-BD76-889F61E588AEQ46765475-35D01D8C-B106-4A2F-8A6E-4CC464C2E816Q47917509-F6C485EF-DC2C-42E7-A4D3-E018EA1F66FBQ50001631-E62AF777-7EAB-46FB-BC77-21536147AC88
P2860
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@ast
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@en
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@nl
type
label
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@ast
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@en
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@nl
prefLabel
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@ast
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@en
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@nl
P2093
P1476
The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
@en
P2093
Andrew A Protter
Andrew Guzzetta
Jessica O'Rear
N Stephen Pollitt
Rodney A Jue
Ute Schellenberger
P304
P356
10.1016/J.ABB.2006.03.028
P407
P577
2006-04-19T00:00:00Z